Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by the spray-drying technique

J. Kang, V. Kumar, D. Yang, P. R. Chowdhury and R. J. Hohl, Cyclodextrin complexation: Influence on the solubility, stability and cytotoxicity of camptothecin, an antineoplastic agent, Eur. J. Pharm. Sci. 15 (2002) 163-170; DOI: 10.1016/s0928-0987(01)00214-7.10.1016/S0928-0987(01)00214-7Search in Google Scholar

A. Miro, F. Quaglia, L. Giannini, B. Cappello and M. I. La Rotonda, Drug/cyclodextrin solid systems in desiging hydrophilic matrices: A strategy to modulate drug delivery rate, Curr. Drug Deliv. 3 (2006) 373-378; DOI: 10.2174/156720106778 558994.Search in Google Scholar

T. Loftsson and M. Brewster, Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization, J. Pharm. Sci. 85 (1996) 1017-1025; DOI: 10.1021/js950534b.10.1021/js950534bSearch in Google Scholar

S. Baboota and S. P. Agarwal, Inclusion complexation of meloxicam with β-cyclodextrin, Ind. J. Pharm. Sci. 64 (2002) 408-411.Search in Google Scholar

T. Loftsson, Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water soluble polymers, Pharmazie 53 (1998) 733-740.Search in Google Scholar

S. G. V. Kumar and D. N. Mishra, Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG, J. Pharm. Soc. Jpn. 126 (2006) 657-664; DOI: 10.1248/yakushi.126.657.10.1248/yakushi.126.657Search in Google Scholar

M. Jug and M. Lacan-Becirevic, Multicomponent complexes of piroxicam with cyclodextrins and hydroxy propyl methyl cellulose, Drug Dev. Ind. Pharm. 30 (2004) 1051-1060; DOI: 10.1081/DDC200040245.Search in Google Scholar

P. Mura, M. T. Faucci and G. P. Bettinetti, The influence of polyvinyl pyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrins, Am. Ass. Pharm. Sci. 13 (2001)187-194.Search in Google Scholar

K. P. R. Chowdry and S. V. Srinivas, Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl-β-cyclodextrins, AAPS PharmSciTech. 7 (2006) Article 79; DOI: 10.1208/pt070379.10.1208/pt070379Search in Google Scholar

L. Ribeiro, T. Loftsson, D. Ferreira and F. Veiga, Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta cyclodextrin binary and ternary complexes, Chem. Pharm. Bull. 51 (2003) 914-922; DOI: 10.1248/cpb.51.914.10.1248/cpb.51.914Search in Google Scholar

P. Mura, F. Maestrelli and M. Cirri, Ternary systems of naproxen with hydroxypropyl-β-cyclodextrins and amino acids, Int. J. Pharm. 260 (2003) 293-302; DOI: 10.1016/S0378-5173(03)00265-5.10.1016/S0378-5173(03)00265-5Search in Google Scholar

P. Mura, G. P. Bettinetti, M. Cirri, F. Maestrelli, M. Sorrenti and L. Catenacci, Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl beta-cyclodextrin ternary system, Eur. J. Pharm. Biopharm. 59 (2005) 99-106; DOI: 10.1016/j.ejpb.2004.05.005.10.1016/j.ejpb.2004.05.00515567306Search in Google Scholar

British Pharmacopoeia 2008, Vol. III, HSM, London 2008, pp. 2867.Search in Google Scholar

T. Higuchi and K. A. Connors, Phase solubility techniques, Adv. Anal. Chem. Instrum. 4 (1965) 117-212.Search in Google Scholar

P. Gupta and A. K. Bansal, Molecular interactions in celecoxib-PVP-meglumine amorphous system, J. Pharm. Pharmacol. 57 (2005) 303-310; DOI: 10.1211/0022357055597.10.1211/002235705559715807985Search in Google Scholar

E. Redenti, L. Szente and J. Szejtli, Drug/cyclodextrin/hydroxy acid mutlicomponent systems. Properties and pharmaceutical applications, J. Pharm. Sci. 89 (2000) 1-8; DOI: 10.1002/(SICI)15206017(200001)89:1<1::AID-JPS1>3.3.CO;2-N.Search in Google Scholar

X. Liu, H. Lin, J. Thenmozhiyal, S. Chan and O. Paul, Inclusion of acitretin into cyclodextrins: Phase solubility, photostability and physicochemical characterization, J. Pharm. Sci. 92 (2003) 2449-2457; DOI: 10.1002/jps.10495.10.1002/jps.1049514603490Search in Google Scholar

S. Baboota, M. Dhaliwal and K. Kohli, Physicochemical characterization, in vitro dissolution behaviour and pharmacodynamics studies of refecoxib-cyclodextrin inclusion compounds preparation and properties of refecoxib hydroxypropyl beta-cyclodextrin inclusion complex, Am. Ass. Pharm. Sci. 2 (2004) 1-25.Search in Google Scholar

L. P. Ruan, B. Y. Yu, G. M. Fu and D. Zhu, Improving the solubility of ampelopsin by solid dispersion and inclusion complexes, J. Pharm. Biomed. Anal. 38 (2005) 457-464; DOI: 10.1016/j.jpba.2005.01.030.10.1016/j.jpba.2005.01.03015925247Search in Google Scholar

S. W. Jun, M. S. Kim, J. S. Kim, H. J. Park, S. Lee, Woo and S. J. Hwang, Preparation and characterization of simvastatin/hydroxypropyl β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm. 66 (2007) 413-421; DOI: 10.1016/j.ejpb.2006.11.013.10.1016/j.ejpb.2006.11.01317240129Search in Google Scholar

N. B. Naidu, K. P. Chowdary, K. V. Murthy, V. Satyanarayana, A. R. Hayman and G. Becket, Physicochemical characterization and dissolution properties of meloxicam cyclodextrin binary systems, J. Pharm. Biomed. Anal. 35 (2004) 75-86; DOI: 10.1016/j.jpba.2004.01.003.10.1016/j.jpba.2004.01.00315030882Search in Google Scholar

C. P. Mora, M. Cirri, B. Allolio, F. Carli and P. Mura, Enhancement of dehydroepiandrosterone solubility and bioavailability and ternary complexation with α-cyclodextrin and glycine, J. Pharm. Sci. 92 (2003) 2177-2184; DOI: 10.1002/jps.10485.10.1002/jps.1048514603503Search in Google Scholar

D. Laveneziana, R. Speranza, P. Raulli and G. Paredi, Ibuprofene-arginine in the managment of pain, Clin. Drug Invest. 11 (1996) 1-7; DOI: 10.2165/00044011-199600111-00003.10.2165/00044011-199600111-00003Search in Google Scholar